KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Capital Leases (2016 - 2018)

Gsk (GSK) has 1 years of Capital Leases data on record, last reported at $56.6 million in Q4 2018.

  • For Q4 2018, Capital Leases changed N/A year-over-year to $56.6 million; the TTM value through Dec 2018 reached $56.6 million, changed N/A, while the annual FY2018 figure was $58.8 million, N/A changed from the prior year.
  • Capital Leases reached $56.6 million in Q4 2018 per GSK's latest filing.
  • Across five years, Capital Leases topped out at $56.6 million in Q4 2018 and bottomed at $56.6 million in Q4 2018.